Axiom Investors LLC Aerie Pharmaceuticals Inc Transaction History

Axiom Investors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $1.94 Million - $2.86 Million	-40,614 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$51.15 - $61.0 $208,436 - $248,575	-4,075 Reduced 9.12%	40,614 $2.2 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $82,732 - $105,917	1,627 Added 3.78%	44,689 $2.67 Million
Q3 2017 Nov 09, 2017	BUY	$48.6 - $60.1 $2.09 Million - $2.59 Million	43,062	43,062 $2.09 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.